Overview

Clinical Trial to Compare Pharmacokinetics After Administration of ATB-101 or Co-administration of ATB-1011 and ATB-1012

Status:
Completed
Trial end date:
2021-07-12
Target enrollment:
Participant gender:
Summary
To compare and evaluate safety and pharmacokinetic Characteristics after administration of ATB-101 or co-administration of ATB-1011 and ATB-1012 in fasted Healthy Adult Volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Autotelicbio
Treatments:
Olmesartan Medoxomil